SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Profit After Tax | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr |
What is the latest Profit After Tax of SYNCOM FORMULATIONS (INDIA) ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹20 Cr |
Mar2017 | ₹11 Cr |
Mar2016 | ₹10 Cr |
How is Profit After Tax of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 26.12 | |
Mar2023 | ₹20 Cr | 1.42 | |
Mar2022 | ₹20 Cr | 87.87 | |
Mar2017 | ₹11 Cr | 1.72 | |
Mar2016 | ₹10 Cr | - |
Compare Profit After Tax of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,680.7 Cr | -4.5% | -6.2% | 22.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -4.5% |
-6.2% |
22.4% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses